中国血液净化

›› 2006, Vol. 5 ›› Issue (11): 776-778.

• 论著 • 上一篇    下一篇

亚甲基四氢叶酸还原酶基因多态性与血液透析患者心、脑血管疾病的关系

黄 雯 李秀季   

  1. 100730 北京，首都医科大学附属北京同仁医院肾内科
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2006-11-12 发布日期:2006-11-12

  • Received:1900-01-01 Revised:1900-01-01 Online:2006-11-12 Published:2006-11-12

RichHTML

0

PDF

245

摘要： 目的 探讨亚甲基四氢叶酸还原酶(methylenetetrahydrofolate reductase,MTHFR)基因多态性与血液透析(hemodialysis, HD)患者心、脑血管疾病的关系。方法 利用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析法检测了首都医科大学附属北京同仁医院肾内科74例HD患者和30例健康者MTHFR C677T基因多态性。结果 HD患者中无心、脑血管疾病组平均年龄明显低于有心、脑血管疾病组(P＜0.01)，而血清肌酐水平明显高于后者(P＜0.01)。HD患者中有心、脑血管疾病组MTHFR T等位基因频率为39.6%，明显高于正常对照组的18.3%(P＜0.05)，亦高于无心、脑血管疾病组的30.0%，但差异无显著性(P＞0.05)。有心、脑血管疾病组MTHFR频率为20.8%，高于无心、脑血管疾病组的12.0%和正常对照组的6.7%，但差异均无显著性(P ＞ 0.05）。结论 本研究尚不能得出MTHFR T/T基因型是血液透析患者发生心、脑血管疾病的一个遗传危险因子。

关键词: 亚甲基四氢叶酸还原酶, 血液透析, 心血管疾病, 基因多态性

Abstract: Objective To investigate the relationship between methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and cardiovascular and cerebrovascular diseases (CVD) in hemodialysis（HD）patients. Methods The technology of polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to detect MTHFR gene C677T polymorphism in 74 HD patients and 30 healthy controls. Results Mean age in HD patients without CVD was significantly lower than that in HD patients with CVD. However, mean levels of serum creatinine in HD patients without CVD were significantly higher than that in HD patients with CVD. The frequency of MTHFR T allele in HD patients with CVD was significantly higher than that in healthy controls (39.6% vs.18.3%, P＜0.05). The frequencies of MTHFR T/T genotype among HD patients with CVD, HD patients without CVD and control subjects were 20.8%, 12.0% and 6.7%, respectively. There was no significant difference in the distributions of MTHFR T/T genotype (P ＞0.05). Conclusion This study can’t confirm that MTHFR T/T genotype is one of the genetic risk factors for CVD occurrence in HD patients.

Key words: Hemodialysis, Cardiovascular diseases, Polymorphism

中图分类号: